Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nostrum Laboratories
Manufacturing
Nostrum Labs pulls another metformin lot over carcinogen fears
Nostrum Laboratories extended its November metformin recall, culling a fourth lot of the popular diabetes med after NDMA showed up in samples.
Fraiser Kansteiner
Jan 26, 2021 10:05am
Nostrum Labs adds another lot to metformin recall
Jan 5, 2021 12:52pm
Yet another pharma recalls metformin on carcinogen concerns
Nov 3, 2020 10:03am